CAPITAL ADJUSTMENT INFORMATION - 13.10.2020;Das Instrument SGT US8125781026 SEATTLE GENETICS DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 12.10.2020 und ex Kapitalmassnahme am 13.10.2020
The instrument SGT US8125781026 SEATTLE GENETICS DL-,001 EQUITY is traded cum capital adjustment on 12.10.2020 and ex capital adjustment on 13.10.2020
The instrument SGT US8125781026 SEATTLE GENETICS DL-,001 EQUITY is traded cum capital adjustment on 12.10.2020 and ex capital adjustment on 13.10.2020